CLINICAL TRIALS PROFILE FOR OCUSERT PILO-40

All Clinical Trials for OCUSERT PILO-40

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02852057 ↗	Effectiveness and Safety of Timolol and Dorzolamide Loaded Contact Lenses	Recruiting	University of Florida	Phase 1	2018-01-18	This study focuses on glaucoma therapy by drug eluting contact lenses. The contact lens will be loaded with timolol maleate and dorzolamide hydrochloride, both of which are commonly used ophthalmic drugs. Additionally, the lenses will contain vitamin E ((+) α-tocopherol) as an additive for achieving extended release of the drugs. This study is to assess the safety of the drug loaded contact lenses and the effectiveness. Effectiveness will be a drop in IOP after using the lenses.

Clinical Trial Conditions for OCUSERT PILO-40

Condition Name

Condition Name for OCUSERT PILO-40
Intervention	Trials
Glaucoma	1

Condition MeSH

Condition MeSH for OCUSERT PILO-40
Intervention	Trials
Glaucoma	1

Clinical Trial Locations for OCUSERT PILO-40

Trials by Country

Trials by Country for OCUSERT PILO-40
Location	Trials
United States	1

Trials by US State

Trials by US State for OCUSERT PILO-40
Location	Trials
Florida	1

Clinical Trial Progress for OCUSERT PILO-40

Clinical Trial Phase

Clinical Trial Phase for OCUSERT PILO-40
Clinical Trial Phase	Trials
Phase 1	1

Clinical Trial Status

Clinical Trial Status for OCUSERT PILO-40
Clinical Trial Phase	Trials
Recruiting	1

Clinical Trial Sponsors for OCUSERT PILO-40

Sponsor Name

Sponsor Name for OCUSERT PILO-40
Sponsor	Trials
University of Florida	1

Sponsor Type

Sponsor Type for OCUSERT PILO-40
Sponsor	Trials
Other	1